Facebook Pixel Upskilling and flexibility are key to staying relevant as hiring grows | BioSpectrum Asia - business - Lisez cet article sur Magzter.com

Essayer OR - Gratuit

Upskilling and flexibility are key to staying relevant as hiring grows

BioSpectrum Asia

|

BioSpectrum Asia June 2025

With ongoing uncertainty, geopolitical tensions, and recession risks, the life sciences job market remains volatile. The year 2024 saw continued layoffs, cautious investor sentiment, and growing competition for fewer job openings. As biopharma companies restructure, hiring patterns are changing, especially at mid and senior levels. What are the current trends, and which sectors are hiring the most? Let's find out.

- Ayesha Siddiqui

The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the worst may be over. Hiring activity is picking up, especially in the Asia-Pacific (APAC) region. A quick search on our sister website, BioSpectrum jobs for April and May 2025 shows strong, diverse recruitment across all levels from internships to senior leadership in key hubs like Singapore, Tokyo, Bengaluru, and Shanghai. Demand is high for clinical research, regulatory affairs, medical science liaison, and digital marketing roles, while leadership hiring focuses on strategy, sales, and commercial functions.

“The pharmaceutical sector's job landscape has showcased an improving trend in recent months. For instance, job postings were up by around 8 per cent in April 2025 compared to the previous month. Similarly, March 2025 also saw job postings register a month-on-month growth of more than 25 per cent,” said Sherla Sriprada, Senior Business Fundamentals Analyst at GlobalData.

This sustained uptick in hiring reflects how companies are responding to evolving workforce dynamics and talent demands.

“The biopharma job market is experiencing several key trends. High executive turnover, as observed in 2024, continues to influence recruitment needs. Companies are leveraging headquarters and regional resources to supplement local talent with global expertise. They are also focusing on candidates who can learn and grow in dynamic environments, due to cautious attitudes toward job changes and the emergence of younger generations,” said Terrence Chen, Manager, Robert Walters China.

Sherla mentions that there have been notable job postings for roles related to clinical trials, regulatory compliance, immuno-oncology, cell & gene therapy, and digital therapeutics. Meanwhile, there is also demand for senior positions and the skills sought for these roles typically include:

  • Leadership experience

PLUS D'HISTOIRES DE BioSpectrum Asia

BioSpectrum Asia

BioSpectrum Asia

Alphamab Oncology appoints Fei Wang as Chief Financial Officer

Hong Kong-based Alphamab Oncology has announced the appointment of Fei Wang as the Chief Financial Officer (CFO).

time to read

1 min

BioSpectrum Asia April 2027

BioSpectrum Asia

BioSpectrum Asia

CarbGeM inks MoU with DSS Imagetech to expand AI business in Indian market

DSS Imagetech, a leading player in medical and research imaging equipment, has announced the signing of a Memorandum of Understanding (MoU) with Japan-based CarbGeM Inc., a developer of artificial intelligence (AI)-powered life science solutions to expand its AI business in the Indian market.

time to read

1 min

BioSpectrum Asia April 2027

BioSpectrum Asia

BioSpectrum Asia

PHCbi introduces LiCellGrow Cell Expansion System

PHC Corporation's Biomedical Division, a global provider of laboratory sample storage and cell cultivation solutions and subsidiary of Japan's PHC Holdings Corporation, has announced the launch of its new cell expansion system LiCellGrow for research use in Japan and other select countries worldwide.

time to read

1 min

BioSpectrum Asia April 2027

BioSpectrum Asia

BioSpectrum Asia

CitiusTech appoints Dhaval Shah as Chief Business Officer - MedTech & Life Sciences

CitiusTech, a leading provider of healthcare technology services driving digital and AI excellence in India, has appointed Dhaval Shah to Chief Business Officer - MedTech & Life Sciences.

time to read

1 min

BioSpectrum Asia April 2027

BioSpectrum Asia

Thermo Fisher expands immunodiagnostics operations with new distribution centre in Uppsala

Thermo Fisher Scientific Inc. has announced the opening of a new 8,000-square-meter distribution & labeling centre supporting its immunodiagnostics business in Uppsala.

time to read

1 min

BioSpectrum Asia April 2027

BioSpectrum Asia

BioSpectrum Asia

Harbour BioMed appoints Dr Jenny Xie as Head of Global External Innovation

Harbour BioMed, a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, has announced the appointment of Dr Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation.

time to read

1 min

BioSpectrum Asia April 2027

BioSpectrum Asia

BioSpectrum Asia

Argo Biopharma ropes in Dr Gena Wang as CFO and CSO

China-based Argo Biopharmaceutical Co., a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, has announced the appointment of Dr Gena Wang as Chief Financial Officer (CFO) and Chief Strategy Officer (CSO), effective March 1, 2026.

time to read

1 min

BioSpectrum Asia April 2027

BioSpectrum Asia

IISc launches "Moonshot" project on brain co-processors supported by Pratiksha Trust

The Indian Institute of Science (IISc), Bengaluru has launched an ambitious \"moonshot\" project to develop brain co-processors that combine neuromorphic hardware and artificial intelligence (AI) algorithms to enhance or restore brain function.

time to read

1 min

BioSpectrum Asia April 2027

BioSpectrum Asia

Korea designs model for accurate and scalable drug-drug interaction prediction

A research team from the School of International Engineering and Science at Jeonbuk National University (JBNU), South Korea, has developed DDINet, a lightweight and scalable model, specifically designed to predict interactions for new, unseen drugs.

time to read

1 min

BioSpectrum Asia April 2027

BioSpectrum Asia

BioSpectrum Asia

Australia-Singapore study advocates role of intranasal vaccine booster against sarbecoviruses

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in Australia, have demonstrated that an intranasal vaccine booster may confer significantly stronger and broader immune responses, and provide robust neutralising antibody and resident T cell responses in the lung and nasal tissues, outperforming conventional mRNA booster vaccination.

time to read

1 min

BioSpectrum Asia April 2027

Listen

Translate

Share

-
+

Change font size